Published March 14, 2024 | Version v1
Journal article Open

Antibody Characterization Report for TGM2 (Protein-glutamine gamma-glutamyltransferase 2)

  • 1. ROR icon Montreal Neurological Institute and Hospital
  • 2. Advanced BioImaging Facility (ABIF)
  • 3. ROR icon McGill University
  • 4. The Neuro's Early Drug Discovery Unit (EDDU)


This report presents a guide to selecting high-quality commercial antibodies against Protein-glutamine gamma-glutamyltransferase 2 (TGM2) by Western blot, immunoprecipitation and immunofluorescence, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. To critically assess the performance of antibodies by Western blot, the antibodies were screened on culture medium as well as lysate. 

The work presented in this study was supported in part by the Michael J. Fox Foundation for Parkinson's research.


TGM2_YCharOS report.pdf

Files (4.1 MB)

Name Size Download all
4.1 MB Preview Download

Additional details